Fubotv earnings beat by $0.10, revenue topped estimates
Investing.com - JMP Securities downgraded Core Scientific Inc . (NASDAQ:CORZ) from Market Outperform to Market Perform following the company’s acquisition announcement by CoreWeave. The stock, currently trading at $12.51 with a market capitalization of $3.73 billion, has experienced a significant 15.64% decline over the past week, according to InvestingPro data.
The downgrade reflects JMP’s view that upside potential for Core Scientific stock is now limited after the acquisition news, which had already driven shares higher on rumors before the official announcement.
JMP noted that while the transaction offers a premium to Core Scientific’s trading levels prior to acquisition rumors, the likelihood of a competing bid from another company appears low.
The CoreWeave acquisition remains subject to both regulatory and shareholder approval, with the transaction expected to close in the fourth quarter of 2025.
JMP Securities now considers the risk/reward profile for Core Scientific to be balanced, stating the stock appears fairly valued at current levels. For deeper insights into Core Scientific’s valuation and comprehensive analysis, including 10+ additional ProTips and detailed financial metrics, visit InvestingPro.
In other recent news, Core Scientific Inc. has announced its acquisition by CoreWeave in an all-stock deal valued at $20.40 per share, with the total transaction valued at approximately $9 billion. This merger will result in Core Scientific shareholders owning about 10% of the new combined company when the deal closes, expected in the fourth quarter of 2025. Despite the acquisition news, Core Scientific’s stock experienced a decline, attributed to investor expectations of a higher valuation and a cash component in the deal. BTIG downgraded Core Scientific from Buy to Neutral following the announcement, highlighting investor expectations for a cash component based on existing contracts between the companies.
Meanwhile, Bernstein has reiterated its Outperform rating on Core Scientific, maintaining a price target of $17.00, while DA Davidson has kept an Underperform rating on CoreWeave. Jefferies has expressed a positive strategic view of the acquisition, suggesting that it would allow CoreWeave to expand its data center capabilities and reduce reliance on third-party developers. Core Scientific, which recently emerged from bankruptcy, has been actively expanding its data center operations to support artificial intelligence and high-performance computing workloads. CoreWeave believes the acquisition will immediately eliminate over $10 billion in future lease overhead and provide access to more attractive capital costs.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.